Skip to main content
. 2018 Apr 19;13(4):e0195898. doi: 10.1371/journal.pone.0195898

Table 1. Baseline characteristics of study patients.

Mean ± SD unless otherwise indicated Group Visits (n = 117) Standard Care (n = 133)
Age (yr) 65.8 ± 8.7 65.0 ± 9.8
Male sex 95.7 96.2
Race
    • Caucasian (%) 75.0 78.2
    • African American (%) 10.3 11.3
    • Asian Pacific Islander (%) 12.9 6.0
    • Hispanic (%) 0 3.0
    • Unknown (%) 1.7 1.5
Duration of Diabetes (years) 13.5 ± 9.4 12.4 ± 9.9
Body mass index (Kg/m2) 32.8 ± 0.5 33.4 ± 0.6
Average number of hospitalizations 13 months prior to the study 0.4 ± 1 0.1 ± 0.4
Hypertension (%) 92.3 85.0
Hyperlipidemia (%) 87.2 91.0
Coronary artery disease (%) 39.3 43.6
Stroke (%) 10.3 3.8
Congestive heart failure (%) 10.3 9.8
COPD (%) 11.1 15.8
Anxiety disorder (%) 32.5 29.3
Mood disorder (%) 35.9 39.1
Schizophrenia/affective (%) 0.9 2.3
Nephropathy (%) 10.3 9.0
Neurophathy (%) 35.0 30.8
Retinopathy (%) 19.7 12.8
Active smoker (%) 21.4 27.1
Previous participation into DM self-care management programs (%) 27.0 20.0
Previous participation into VHA weight loss program (MOVE!) (%) 3.4 6.0
UKPDS 10-yr Coronary Risk 0.35 ± 0.19 0.36 ± 0.20
Systolic blood pressure (mmHg) 136.5 ± 19.0 136.2 ± 17.4
Diastolic blood pressure (mmHg) 75.1 ± 11.4 75.3 ± 10.5
Total Cholesterol (mg/dL) 155.2 ± 33.5 165.3 ± 39.7
HDL Cholesterol (mg/dL) 37.8 ± 10.9 38.1 ± 9.5
LDL Cholesterol (mg/dL) 87.6 ± 29.8 93.7 ± 33.7
Hemoglobin A1c (%) 8.2 ± 1.5 8.2 ± 1.3
Creatinine (mg/dL) 1.1 ± 0.4 1.1 ± 0.3
Microalbumin/creatinine ratio 198.4 ± 581.6 114.3 ± 267.4
SF-36v Physical component scale 39.2 ± 9.7 39.3 ± 9.8
SF-36v Mental component scale 48.8 ± 11.0 50.4±11.7
Healthcare Costs 13 months before the study, $ 22062 ± 67524 15200 ± 23812

SI conversion factors: cholesterol mg/dL to mmol/L, multiply by 0.0259; creatinine mg/dL to umol/L, multiply by 88.4 . Abbreviations: COPD = chronic obstructive pulmonary disease, DM = Diabetes, UKPDS = United Kingdom Prospective Diabetes Study Coronary Event Risk score